Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Long-Term Deferred Tax (2020 - 2025)

Historic Long-Term Deferred Tax for Neurocrine Biosciences (NBIX) over the last 6 years, with Q4 2025 value amounting to $320.3 million.

  • Neurocrine Biosciences' Long-Term Deferred Tax fell 3405.39% to $320.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $320.3 million, marking a year-over-year decrease of 3405.39%. This contributed to the annual value of $320.3 million for FY2025, which is 3405.39% down from last year.
  • Latest data reveals that Neurocrine Biosciences reported Long-Term Deferred Tax of $320.3 million as of Q4 2025, which was down 3405.39% from $368.5 million recorded in Q3 2025.
  • In the past 5 years, Neurocrine Biosciences' Long-Term Deferred Tax ranged from a high of $536.8 million in Q2 2025 and a low of $310.4 million during Q3 2021
  • In the last 4 years, Neurocrine Biosciences' Long-Term Deferred Tax had a median value of $378.2 million in 2024 and averaged $391.8 million.
  • Per our database at Business Quant, Neurocrine Biosciences' Long-Term Deferred Tax surged by 3394.93% in 2024 and then tumbled by 3405.39% in 2025.
  • Quarter analysis of 4 years shows Neurocrine Biosciences' Long-Term Deferred Tax stood at $310.4 million in 2021, then grew by 16.82% to $362.6 million in 2023, then soared by 33.95% to $485.7 million in 2024, then tumbled by 34.05% to $320.3 million in 2025.
  • Its Long-Term Deferred Tax was $320.3 million in Q4 2025, compared to $368.5 million in Q3 2025 and $536.8 million in Q2 2025.